Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Journal of Neuroimmunology|June 8, 2020
Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infectionMarco Chiarini, Simone Paghera, Daniele Moratto, et al.
Journal of Neuroimmunology|July 10, 2007
IFNbeta bioavailability in multiple sclerosis patients: MxA versus antibody-detecting assaysRuggero Capra, Alessandra Sottini, Cinzia Cordioli, et al.
Journal of Neurology|June 23, 2014
Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosisLaura Parisi, Maria A Rocca, Flavia Mattioli, et al.
Journal of Neuroimmunology|December 4, 2014
Immunological biomarkers identifying natalizumab-treated multiple sclerosis patients at risk of progressive multifocal leukoencephalopathyFederico Serana, Marco Chiarini, Alessandra Sottini, et al.
Neuroimage|December 25, 2007
The topographical distribution of tissue injury in benign MS: a 3T multiparametric MRI studyAntonia Ceccarelli, Maria A Rocca, Elisabetta Pagani, et al.
Clinical Immunology (Orlando, Fla.)|August 16, 2012
Peripheral accumulation of newly produced T and B lymphocytes in natalizumab-treated multiple sclerosis patientsCinzia Zanotti, Marco Chiarini, Federico Serana, et al.
Journal of Neurology|January 23, 2014
The MoSt Project--more steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in ItalyRuggero Capra, Mario Alberto Battaglia, Antonio Gaudioso, et al.
Viral Immunology|August 25, 2017
Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal LeukoencephalopathyFrancesca Rossi, Luca Prosperini, Nicola De Rossi, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|November 18, 2020
Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study resultsRuggero Capra, Vincenzo Brescia Morra, Massimiliano Mirabella, et al.
Journal of Neuroimmunology|November 15, 2011
Opposite effects of interferon-β on new B and T cell release from production sites in multiple sclerosis patientsCinzia Zanotti, Marco Chiarini, Federico Serana, et al.
Pageof 9